spacer
home > pmps > autumn 2017 > sterilisation steels
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Sterilisation Steels

Clean and safe environments are essential criteria for compliance with UK Medicines and Healthcare products Regulatory Agency (MHRA) standards. To support this, furniture and equipment must facilitate Good Manufacturing Practice. This means it must be chemically inert and robust enough to withstand thorough cleaning and maintenance.

MHRA hygiene audits are renowned for being necessarily stringent, and a clean and safe environment is the top criterion for compliance. In particular, it is important that clean rooms are designed with contamination prevention and control practices in mind. This is where stainless steel comes in. The material has been a standard feature in clean rooms and laboratories for decades.

Stainless steel is an alloy of iron that has a minimum of 10.5% chromium, which provides a supplementary ‘passive layer’ of oxide on the surface of the steel. Increasing the percentage of chromium improves corrosion resistance, and this is generally considered to be the main selling point of stainless steel. Adding elements such as manganese, molybdenum, nickel and nitrogen enhances this further and can also make the metal more malleable and thus easier to manufacture into different designs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which manufactures hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for clean room users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

NDA Group Releases Data Comparing FDA and EMA Ahead of Annual DIA Europe in Basel

Today NDA Group announced their findings from its fifth annual comparison of drug approvals in Europe and the United States, in preparation for this year’s DIA Europe in Basel, Switzerland. The figures highlight the continued differences between the two regions, and the need for a global approach to drug development to ensure success across both continents.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

T3: Trials, Tech and Transformation

30-31 May 2018, Raleigh Convention Center, Raleigh, NC

T3 is back for 2018 to provide you with the latest updates and top tips from across the clinical trials landscape. Connecting leading experts, influencers and innovators from pharma, biotech, CROs, patient advocacy groups, academia and beyond, T3 is themeeting place for all stakeholders to voice their questions, connect with peers, and get direct feedback from an expert speaker line-up.And this year, we're in Raleigh.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement